A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS). [electronic resource]
Producer: 20210715Description: 607-609 p. digitalISSN:- 1179-1942
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.